scholarly article | Q13442814 |
P50 | author | Marc Bonnefoy | Q73084273 |
P2093 | author name string | René Ecochard | |
Thomas Gilbert | |||
Jocelyne Drai | |||
Emilie Blond | |||
Charlotte Cuerq | |||
Sylvain Roche | |||
Jean-Yves Bar | |||
Marine Haution-Bitker | |||
P2860 | cites work | Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging | Q24629027 |
“Mini-mental state” | Q25938989 | ||
Obesity and dementia: adipokines interact with the brain. | Q30361051 | ||
Predicting the Rate of Cognitive Decline in Alzheimer Disease: Data From the ICTUS Study | Q31123380 | ||
Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's disease | Q33681922 | ||
Low plasma leptin in cognitively impaired ADNI subjects: gender differences and diagnostic and therapeutic potential | Q33692408 | ||
Reduced lean mass in early Alzheimer disease and its association with brain atrophy | Q33791606 | ||
Leptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices | Q34075070 | ||
Adiponectin: more than just another fat cell hormone? | Q34217331 | ||
Adipokines: a link between obesity and dementia? | Q34496620 | ||
Plasma leptin levels are not predictive of dementia in patients with mild cognitive impairment | Q34630992 | ||
Mechanisms of leptin action and leptin resistance | Q34701125 | ||
Adiponectin protects rat hippocampal neurons against excitotoxicity | Q35080193 | ||
Obesity and the ageing brain: could leptin play a role in neurodegeneration? | Q35367422 | ||
Central obesity in the elderly is related to late-onset Alzheimer disease | Q35980793 | ||
Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer's disease. | Q51040272 | ||
Peripheral Blood Adipokines and Insulin Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analysis. | Q53374041 | ||
Altered serum levels of adipokines and insulin in probable Alzheimer's disease. | Q53462386 | ||
Circulating Adiponectin Levels and Mortality in Elderly Men With and Without Cardiovascular Disease and Heart Failure | Q57416311 | ||
Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease | Q57812922 | ||
Alzheimer's disease promotion by obesity: induced mechanisms-molecular links and perspectives | Q36026292 | ||
Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study | Q36439930 | ||
Midlife and late-life obesity and the risk of dementia: cardiovascular health study | Q36441882 | ||
National, regional, and global trends in adult overweight and obesity prevalences | Q36526941 | ||
Obesity, leptin, and Alzheimer's disease | Q36587781 | ||
Leptin, mild cognitive impairment, and dementia among elderly women | Q36686873 | ||
Leptin increases adult hippocampal neurogenesis in vivo and in vitro | Q36737548 | ||
IANA (International Academy on Nutrition and Aging) Expert Group: weight loss and Alzheimer's disease. | Q36742093 | ||
Leptin Dysfunction and Alzheimer's Disease: Evidence from Cellular, Animal, and Human Studies. | Q36840174 | ||
Leptin reduces Alzheimer's disease-related tau phosphorylation in neuronal cells | Q36959116 | ||
Lipids and adipokines as risk factors for Alzheimer's disease. | Q37066912 | ||
Incidence of Dementia over Three Decades in the Framingham Heart Study | Q37090279 | ||
Predictors of progression of cognitive decline in Alzheimer's disease: the role of vascular and sociodemographic factors | Q37292162 | ||
Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis | Q37543864 | ||
Adiposity hormones and dementia | Q37793535 | ||
Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. | Q37846798 | ||
Weight loss and Alzheimer's disease: temporal and aetiologic connections | Q38056572 | ||
The global prevalence of dementia: a systematic review and metaanalysis | Q38073027 | ||
Obesity as a risk factor for Alzheimer's disease: the role of adipocytokines | Q38189680 | ||
2003-2013: a decade of body mass index, Alzheimer's disease, and dementia | Q38242147 | ||
Effect of leptin replacement on brain structure in genetically leptin-deficient adults | Q38330581 | ||
Regulation of plasma leptin in mice: influence of age, high-fat diet, and fasting | Q38344505 | ||
Serum high-molecular-weight adiponectin level and incident dementia in patients with vascular risk factors | Q38930559 | ||
BMI and risk of dementia in two million people over two decades: a retrospective cohort study | Q39374033 | ||
Late-Life Vascular Risk Factors and Alzheimer Disease Neuropathology in Individuals with Normal Cognition | Q39497338 | ||
Leptin induces proliferation of neuronal progenitors and neuroprotection in a mouse model of Alzheimer's disease | Q39780930 | ||
Leptin: a novel therapeutic target in Alzheimer's disease? | Q40292339 | ||
Association of adiponectin, leptin and resistin with inflammatory markers and obesity in dementia. | Q41039610 | ||
Diagnosis of Alzheimer's disease patients with rapid cognitive decline in clinical practice: interest of the Deco questionnaire | Q42599015 | ||
Abdominal Fat, Adipose-Derived Hormones and Mild Cognitive Impairment: The J-SHIPP Study | Q42800573 | ||
Does midlife obesity really lower dementia risk? - Authors' reply | Q43515952 | ||
DSM-5 and neurocognitive disorders | Q43995936 | ||
Weight loss precedes dementia in community-dwelling older adults. | Q44061741 | ||
Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity | Q44526989 | ||
Overweight and obesity in old age are not associated with greater dementia risk | Q46191719 | ||
Analytical validation and biological evaluation of a high molecular-weight adiponectin ELISA. | Q46939250 | ||
Serum leptin and risk of cognitive decline in elderly italians. | Q48153098 | ||
Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum. | Q48301054 | ||
Influence of oxidative stress biomarkers on cognitive decline. | Q48376204 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | clinical psychology | Q199906 |
P304 | page(s) | 1255-1264 | |
P577 | publication date | 2018-01-01 | |
P1433 | published in | Journal of Alzheimer's Disease | Q6294755 |
P1476 | title | Association between Peripheral Leptin and Adiponectin Levels and Cognitive Decline in Patients with Neurocognitive Disorders ≥65 Years | |
P478 | volume | 66 |
Q92861522 | Links Between Adiponectin and Dementia: From Risk Factors to Pathophysiology | cites work | P2860 |
Search more.